BRPI0400565A - Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody - Google Patents
Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibodyInfo
- Publication number
- BRPI0400565A BRPI0400565A BR0400565-1A BRPI0400565A BRPI0400565A BR PI0400565 A BRPI0400565 A BR PI0400565A BR PI0400565 A BRPI0400565 A BR PI0400565A BR PI0400565 A BRPI0400565 A BR PI0400565A
- Authority
- BR
- Brazil
- Prior art keywords
- recombinant antibody
- recombinant
- isolated
- nucleic acid
- expression vector
- Prior art date
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
"MOLéCULA DE áCIDO NUCLEICO ISOLADA, VETOR DE EXPRESSãO RECOMBINANTE, CéLULA HOSPEDEIRA, MéTODO PARA PRODUZIR UM ANTICORPO RECOMBINANTE ISOLADO, ANTICORPO RECOMBINANTE, E, USO DE UM ANTICORPO RECOMBINANTE". Anticorpos recombinantes são apresentados. As seq³ências de ácido nucleico e de aminoácido codificado das imunoglobulinas de cadeia pesada e leve de anticorpos monoclonais humanos neutralizadores do vírus da raiva, e seu uso, são descritas."ISOLATED NUCLEIC ACID MOLECULE, RECOMBINANT EXPRESSION VECTOR, HOST STONE CELL, METHOD TO PRODUCE AN ISOLATED RECOMBINANT ANTIBODY, AND, USE OF A RECOMBINANT ANTIBODY". Recombinant antibodies are presented. The nucleic acid and encoded amino acid sequences of the heavy and light chain immunoglobulins of human rabies virus neutralizing monoclonal antibodies, and their use, are described.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0400565-1A BRPI0400565A (en) | 2004-02-18 | 2004-02-18 | Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0400565-1A BRPI0400565A (en) | 2004-02-18 | 2004-02-18 | Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0400565A true BRPI0400565A (en) | 2005-10-11 |
Family
ID=35062869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0400565-1A BRPI0400565A (en) | 2004-02-18 | 2004-02-18 | Isolated nucleic acid molecule, recombinant expression vector, host cell, method for producing an isolated recombinant antibody, recombinant antibody, and use of a recombinant antibody |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0400565A (en) |
-
2004
- 2004-02-18 BR BR0400565-1A patent/BRPI0400565A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3683235T3 (en) | Anti-il-33 antibodies and uses thereof | |
| CL2008002349A1 (en) | Human cd37-binding antibody molecule; DNA molecule that encodes it; expression vector and host cell; method of producing said antibody; pharmaceutical composition comprising it; In vitro method of suppressing cd37-expressing b cells in a population of cells. | |
| CY1118443T1 (en) | ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES | |
| AR046833A1 (en) | ANTI-INTERLEUQUINA ANTIBODIES-10 | |
| IL310186B1 (en) | Plasma kallikrein-binding proteins | |
| AR038568A1 (en) | ANTI-A BETA ANTIBODIES AND ITS USE | |
| AR109355A2 (en) | OX40 HUMAN RECEIVER UNION MOLECULES | |
| BRPI0407233A (en) | Neutralizing antibody, antibody molecule, cdr-grafted antibody, isolated dna sequence, cloning or expression vector, host cell, process for producing the antibody molecule, and, pharmaceutical composition | |
| AR052889A1 (en) | ANTIBODIES AGAINST INTERLEUQUINE-1 BETA | |
| AR045056A1 (en) | ANTI-NGF ANTIBODIES NEUTRALIZING HUMANS AS SELECTIVE INHIBITORS OF THE NGF ROAD | |
| CY1114851T1 (en) | IL-1BIT BINDING antibodies and their fragments | |
| BRPI0812878C1 (en) | isolated antibody or functional part thereof, vector, method for producing an antibody or a functional part thereof, for producing an antibody-producing cell and for producing an antibody capable of specifically binding to rsv, composition, and use of an antibody or functional part of it or of a composition or vector | |
| PE20110225A1 (en) | COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING COMPLEMENT PROTEIN C5 | |
| UY29573A1 (en) | DIRECTED ANTIBODIES AGAINST CD20 AND ITS USES | |
| BRPI0619595B8 (en) | neutralizing antibody, isolated DNA sequence, cloning or expression vector, host cell, process for producing an antibody, pharmaceutical composition, and use of a humanized neutralizing antibody | |
| AR040046A1 (en) | ANTI-IGFR HUMAN NEUTRALIZING ANTIBODY | |
| EA200800953A1 (en) | HUMAN MONOCLONAL ANTIBODIES TO CD70 | |
| ME00812B (en) | Human antibodies to human delta like ligand 4 | |
| EA200970477A1 (en) | HUMAN MONOCLONAL ANTIBODIES TO BTLA AND METHODS OF APPLICATION | |
| ATE444308T1 (en) | FUSION PROTEINS OF HUMANIZED G250 SPECIFIC ANTIBODIES AND USES THEREOF | |
| BRPI0717768B8 (en) | antibody, epitope, isolated DNA sequence, cloning or expression vector, process for producing the antibody, pharmaceutical composition, and use of an antibody | |
| RU2004115112A (en) | HUMAN ANTIBODIES WITH MN BINDING ACTIVITY AND CELLULAR ADHESION NEUTRALIZATION | |
| JP2004528803A5 (en) | ||
| TW200635946A (en) | Binding proteins specific for human matriptase | |
| PE20230384A1 (en) | CD163 ANTIBODIES OR BINDING PROTEINS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 11, 8O C/C 13, 24 E 25 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |
|
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07K 16/08 , C12N 15/11 , C12N 15/63 , C12N 15/13 Ipc: C07K 16/08 (2026.01), C12N 15/11 (2006.01), C12N 1 |